Skip to main content

Table 5 Clinical outcomes for patients according to demographic characteristics of interest (clinically evaluable population at the post-therapy/test of cure visit)

From: Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

 

Clinical Outcome

Subgroup

n

Clinical cure, n (%)

All patients

357

332 (93.0)

Bacteremia

14

14 (100)

S pneumoniae bacteremia

9

9 (100)

Age ≥ 65 years

47

45 (95.7)

Chest x-ray findings

  

   Unilateral

256

236 (92.2)

   Bilateral

97

92 (94.8)

   Single lobe*

303

282 (93.1)

   Multiple lobes

42

38 (90.5)

Fever >38°C (oral or equivalent)

123

117 (95.1)

PSI

  

   Class I

187

176 (94.1)

   Class II

126

115 (91.3)

   Class III

35

32 (91.4)

   Class IV

9

9 (100)

  1. PSI = pneumonia severity index.
  2. *"Single lobe" could apply to either unilateral or bilateral lung involvement (i.e. 1 lobe per right and/or left lung).